In order to validate our findings and to identify possible underlying molecular features, we used several BCP-ALL cell lines with different cytogenetic backgrounds for studying the effects of dasatinib and TGF-β1 on TGFβ signaling activity in BCP-ALL. Here, TGFB1 is linked to acute lymphoblastic leukemia.